Audited Financiao Results for the quarter anf financial year ended March 31 2026

Exceptional itemRevenue growth above 20%EBITDA margin compressionDebt to equity above the thresholdResults View source PDF Explain this filing

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.7%Reaction day

₹1848.30

prior close

₹1930.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.2%+3.5% vs market

Hospital peers, median of 23sector+0.3%+4.5% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Smallcap 250 and 4.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.7

15m

+0.2

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.7+1.2+3.5+0.3+4.5

Next day

+2.7+1.4+1.3+0.1+2.6

+4.1+2.0+2.2-0.4+4.5

+5.0+1.3+3.7-0.5+5.5

+3.2+0.5+2.7-1.0+4.2

+4.3+1.0+3.3-1.4+5.6

+5.8+1.7+4.2-0.6+6.5

15d

+0.8+3.5-2.8+0.6+0.2

+5.6+5.5+0.1+1.1+4.5

+11.1+6.3+4.8+4.7+6.4

+2.5+9.4-6.9+4.1-1.6

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya reported standalone revenue from operations of Rs 39,751 million for FY26, up 10.7% from Rs 35,901 million in FY25. Net profit grew 16.7% to Rs 5,031 million from Rs 4,311 million. EBITDA margin expanded to 21.1% from 18.7% year-on-year. The company declared a final dividend of Rs 4.50 per share and received an unmodified (clean) audit opinion from Deloitte Haskins & Sells LLP with no going concern issues. An exceptional item of Rs 452.76 million was recorded due to increased gratuity and leave liabilities from new Labour Codes. The company has pending corporate restructuring: a merger of MMRHL (via NCLT) and a demerger of NHIC's clinical services. The board also sought approval to issue debt securities up to Rs 1,500 crore.

Likely market impact

Strong financial performance with margin expansion and double-digit profit growth is positive for shareholders. The clean audit opinion removes key risk concerns, though the exceptional charge and higher debt levels warrant monitoring.

By the numbersConsolidated · Q4 FY26 vs Q4 FY25

	Q4 FY26	Q4 FY25	Change
Revenue	₹2,594 Cr	₹1,475 Cr	+75.8%
Operating profit	₹264.9 Cr	₹234.5 Cr	+13.0%
Profit after tax	₹224.0 Cr	₹197.3 Cr	+13.5%
EBITDA margin	19.7%	23.7%	−4.0 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.